Budget impact of Medicaid Section 1115 demonstrations for early HIV treatment

Health Care Financing Review

Volumn 26, Issue 4, 2005, Pages 67-80

  Schackman, Bruce R ^a   Freedberg, Kenneth A ^b,c   Goldie, Sue J ^b   Weinstein, Milton C ^b   Swartz, Katherine ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BUDGET; COST BENEFIT ANALYSIS; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH PROGRAM; HIGH RISK PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAID; MEDICARE; PROSPECTIVE PAYMENT; RESOURCE ALLOCATION;

BUDGETS; EARLY DIAGNOSIS; GEORGIA; HIV INFECTIONS; HUMANS; MASSACHUSETTS; MEDICAID; PILOT PROJECTS; UNITED STATES;

EID: 24144495073     PISSN: 01958631     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Aldridge, C., Davis, D., Doyle, A., et al.: National ADAP Monitoring Project: Annual Report. National Alliance of State and Territorial AIDS Directors, AIDS Treatment Data Network, and the Henry J. Kaiser Family Foundation. Washington, DC and New York, NY. April 2002.
2. Bozzette, S. A., Berry, S.H., Duan, N., et al.: The Care of HIV-Infected Adults in the United States. New England Journal of Medicine 339(26):1897-1904, December 1998.
3. Bozzette, S. A., Joyce, G., McCaffrey, D.F., et al.: Expenditures for the Care of HIV-Infected Patients in the Era of Highly Active Antiretroviral Therapy. New England Journal of Medicine 344(11):817-823, March 2001.
4. Buchanan, R. J. and Smith, S.R.: Medicaid Policies for HIV-Related Prescription Drugs. Health Care Financing Review 15(3):43-61, Summer 1994.
5. Doyle, A. and Jefferys, R.: National ADAP Monitoring Project: Annual Report. National Alliance of State and Territorial AIDS Directors and AIDS Treatment Data Network. Washington, DC and New York, NY. March 2000.
6. Drug Topics: 1999 Red Book. Medical Economics. Montvale, NJ.
7. Federal Register: 62 (226):62613-62615. November 24, 1997.
8. Federal Register: 64 (52):13428-13430. March 18, 1999.
9. Federal Register. 59 (186):49249. September 27, 1994.
10. Fakhraei, S. H., Kaelin, J.J., and Conviser, R.: Comorbidity-Based Payment Methodology for Medicaid Enrollees with HIV/AIDS. Health Care Financing Review 23 (2):53-68, Winter 2001.
11. Frank, R.G. and McGuire, T.G.: Health Care Financing Reform and State Mental Health Systems. In Rich, R.F. and White, W.D. (eds.): Health Policy, Federalism, and the American States. The Urban Institute Press. Washington, DC. 1996.
12. Freedberg, K. A., Losina, E., Weinstein, M.C., et al.: The Cost Effectiveness of Combination Antiretroviral Therapy for HIV Disease. New England Journal of Medicine 344 (11):824-831, March 2001.
13. Gebo, K. A., Chaisson, R.E., Folkemer, J. G., et al.: Costs of HIV Medical Care in the Era of Highly Active Antiretroviral Therapy. AIDS 13(8):963-969, May 1999.
14. Goldman, D. P., Bhattacharya, J., Leibowitz, A.A. et al.: The Impact of State Policy on the Costs of HIV Infection. Medical Care Research and Review 58(1):31-53, March 2001.
15. Hammer, S. M., Squires, K.E., Hughes, M.D., et al: A Controlled Trial of Two Nucleoside Analogues Plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 Per Cubic Millimeter or Less. New England Journal of Medicine 337(11):725-733, September 1997.
16. Lambrew, J.: Section 1115 Waivers in Medicaid and the State Children's Health Insurance Program: An Overview. Kaiser Commission on Medicaid and the Uninsured. Washington, DC. 2001.
17. Laurence, L.: Medicaid's Catch-22. Kaiser Daily HIV/AIDS Report. March 13, 2001.
18. Levi, J. and Kates, J.: HIV: Challenging the Health Care Delivery System. American Journal of Public Health 90(7):1033-1036. 2000.
19. Lucas, G. M., Chaisson, R.E., and Moore, R.D.: Highly Active Antiretroviral Therapy in a Large Urban Clinic: Risk Factors for Virologic Failure and Adverse Drug Reactions. Annals of Internal Medicine 131(2):81-87, July 1999.
20. Milligan, C.: Section 1115 Waivers and Budget Neutrality: Using Medicaid Funds to Expand Coverage. Academy for Health Services Research and Policy State Coverage Initiatives Issue Brief. Washington, DC. 2001.
21. National Governors Association: Letter to Senator Baucus and Senator Grassley. October 1, 2002. Internet address: http://www.nga.org/nga/ legislativeUpdate/1,1169,C_LETTER^D_4448,00.ht ml (Accessed 2005.)
22. Schackman, B.R., Goldie, S.J., Weinstein, M.C., et al.: Cost-Effectiveness of Earlier Initiation of Antiretroviral Therapy for Uninsured HIV-Infected Adults. American Journal of Public Health 91(9):1456-1463, September 2001.
23. Staszewski, S., Morales-Ramirez, J., Tashima, K.T., et al.: Efavirenz Plus Zidovudine and Lamivudine, Efavirenz Plus Indinavir, and Indinavir Plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults. New England Journal of Medicine 341(25):1865-1873, December 1999.
24. U.S. Department of Health and Human Services: Health Insurance Flexibility and Accountability (HIFA) Demonstration Initiative. 2003a. Internet address: http://www.cms.hhs.gov/hifa. (Accessed 2005.)
25. U.S. Department of Health and Human Services: State Waiver Programs and Demonstrations 2003b. Internet address: http://cms.hhs.gov/medicaid/ waivers/waivermap.asp. (Accessed 2005.)
26. U.S. Department of Health and Human Services: Panel on Clinical Practices for Treatment of HIV Infection: Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents. February 5, 2001. Internet address: http://www. hivatis.org/guidelines/adult/archive/AA_020501/i ndex.html (Accessed 2005.)
27. U.S. General Accounting Office: Medicaid Section 1115 Waivers: Flexible Approach to Approving Demonstrations Could Increase Federal Costs. GAO/HEHS-96-44. U.S. Government Printing Office. Washington, DC. November 1995.
28. U.S. General Accounting Office: Medicaid and SCHIP: Recent HHS Approvals of Demonstration Waiver Projects Raise Concerns. GAO-02-817. U.S. Government Printing Office. Washington, DC. July 2002.
29. Westmorland, T.: Medicaid & HIV/AIDS Policy: A Basic Primer. The Henry J. Kaiser Family Foundation. Washington, DC. 1999.